Laboratorios Clausen has been recently approved by Ministry of Health in Uruguay (MSP) for manufacturing oral dosage forms containing cytostatic active substances. This certification enlarges our product’s portfolio and third party services.
Cuban Health Authority Audit (Cecmed)
Last February, the Center for State Control of Drugs, Equipment and Devices Therapeutic (CECMED) of Cuba inspected and approved the High Tech Pharmaceutical facility of Laboratorios Clausen S.A in Montevideo – Uruguay, for pentavalent vaccine filling. Others inpections GSK and EMA
GF Optical Inspection Machine Incorporation
Clausen has adquired an optical syringe inspection machine The syringe inspection for visible foreign particles is done over 100% of produced units, which is presently performed by manual process according to Pharmacopeias.
A new Suprimun clinical study conducted in Uruguayan patients
Laboratorios Clausen SA is pleased to report that it has completed a new clinical study in Uruguay that records the clinical experience with Suprimun / Micoflavin / Myclausen.
Laboratorios Clausen has been recently approved by Ministry of Health in Uruguay (MSP) for manufacturing Capecitabine in its segregated oral facility. This extension of GMP certificate to include an oncologic product enlarges our product portfolio and third party services.
Enoxaparin Manufacturing for Phoenix-GSK
On July 2012 and given injectable facility upgrade, Clausen started manufacturing Enoxaparin in prefilled syringes for Laboratorios Phoenix, part of GlaxoSmithKline Group (GSK).